HIV-1 immunogen: Final Phase II data

Final data from a single-blind, Italian Phase II trial in 49 evaluable antiretroviral therapy-naïve HIV patients showed CD4 T cell count remained stable through week 28 with 3 injections of the HIV-1 ...